These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 30524199)

  • 1. Corrigendum to "Redox Signaling in Diabetic Nephropathy: Hypertrophy versus Death Choices in Mesangial Cells and Podocytes".
    Manda G; Checherita IA; Comanescu MV; Hinescu ME
    Mediators Inflamm; 2018; 2018():8515032. PubMed ID: 30524199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Redox Signaling in Diabetic Nephropathy: Hypertrophy versus Death Choices in Mesangial Cells and Podocytes.
    Manda G; Checherita AI; Comanescu MV; Hinescu ME
    Mediators Inflamm; 2015; 2015():604208. PubMed ID: 26491232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glomerular mesangial cell and podocyte injuries in diabetic nephropathy.
    Tung CW; Hsu YC; Shih YH; Chang PJ; Lin CL
    Nephrology (Carlton); 2018 Oct; 23 Suppl 4():32-37. PubMed ID: 30298646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Berberine attenuates podocytes injury caused by exosomes derived from high glucose-induced mesangial cells through TGFβ1-PI3K/AKT pathway.
    Wang YY; Tang LQ; Wei W
    Eur J Pharmacol; 2018 Apr; 824():185-192. PubMed ID: 29378192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of growth arrest-specific gene 6 in diabetic nephropathy.
    Arai H; Nagai K; Doi T
    Vitam Horm; 2008; 78():375-92. PubMed ID: 18374201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypertrophy and loss of podocytes in diabetic nephropathy.
    Miyauchi M; Toyoda M; Kobayashi K; Abe M; Kobayashi T; Kato M; Yamamoto N; Kimura M; Umezono T; Suzuki D
    Intern Med; 2009; 48(18):1615-20. PubMed ID: 19755763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wnt signaling and podocyte dysfunction in diabetic nephropathy.
    Bose M; Almas S; Prabhakar S
    J Investig Med; 2017 Dec; 65(8):1093-1101. PubMed ID: 28935636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p27(Kip1) Knockout mice are protected from diabetic nephropathy: evidence for p27(Kip1) haplotype insufficiency.
    Wolf G; Schanze A; Stahl RA; Shankland SJ; Amann K
    Kidney Int; 2005 Oct; 68(4):1583-9. PubMed ID: 16164635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corrigendum to "A Liquid-Based Cytology System, without the Use of Cytocentrifugation, for Detection of Podocytes in Urine Samples of Patients with Diabetic Nephropathy".
    Kimura M; Toyoda M; Saito N; Kaneyama N; Miyatake H; Tanaka E; Komaba H; Hara M; Fukagawa M
    J Diabetes Res; 2020; 2020():3623147. PubMed ID: 32685555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Podocyte hypertrophy in diabetic nephropathy.
    Kim NH
    Nephrology (Carlton); 2005 Oct; 10 Suppl():S14-6. PubMed ID: 16174280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gas6 induces Akt/mTOR-mediated mesangial hypertrophy in diabetic nephropathy.
    Nagai K; Matsubara T; Mima A; Sumi E; Kanamori H; Iehara N; Fukatsu A; Yanagita M; Nakano T; Ishimoto Y; Kita T; Doi T; Arai H
    Kidney Int; 2005 Aug; 68(2):552-61. PubMed ID: 16014032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Podocyte biology in diabetic nephropathy.
    Li JJ; Kwak SJ; Jung DS; Kim JJ; Yoo TH; Ryu DR; Han SH; Choi HY; Lee JE; Moon SJ; Kim DK; Han DS; Kang SW
    Kidney Int Suppl; 2007 Aug; (106):S36-42. PubMed ID: 17653209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Research advances in podocyte injury and its role in diabetic nephropathy.
    Li JH; Tao JL; Li H
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2010 Oct; 32(5):590-6. PubMed ID: 21050569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kidney glycosphingolipids are elevated early in diabetic nephropathy and mediate hypertrophy of mesangial cells.
    Subathra M; Korrapati M; Howell LA; Arthur JM; Shayman JA; Schnellmann RG; Siskind LJ
    Am J Physiol Renal Physiol; 2015 Aug; 309(3):F204-15. PubMed ID: 26041445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advanced glycation end-products induce cell cycle arrest and hypertrophy in podocytes.
    Rüster C; Bondeva T; Franke S; Förster M; Wolf G
    Nephrol Dial Transplant; 2008 Jul; 23(7):2179-91. PubMed ID: 18344241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesangial medium with IgA1 from IgA nephropathy inhibits nephrin expression in mouse podocytes.
    Wang C; Liu X; Ye Z; Zhang J; Tang H; Chen Z; Zhang H; Lou T
    Eur J Clin Invest; 2009 Jul; 39(7):561-7. PubMed ID: 19397686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetic kidney lesions of GIPRdn transgenic mice: podocyte hypertrophy and thickening of the GBM precede glomerular hypertrophy and glomerulosclerosis.
    Herbach N; Schairer I; Blutke A; Kautz S; Siebert A; Göke B; Wolf E; Wanke R
    Am J Physiol Renal Physiol; 2009 Apr; 296(4):F819-29. PubMed ID: 19211686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accumulation of worn-out GBM material substantially contributes to mesangial matrix expansion in diabetic nephropathy.
    Kriz W; Löwen J; Federico G; van den Born J; Gröne E; Gröne HJ
    Am J Physiol Renal Physiol; 2017 Jun; 312(6):F1101-F1111. PubMed ID: 28228399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesangial medium from IgA nephropathy patients induces podocyte epithelial-to-mesenchymal transition through activation of the phosphatidyl inositol-3-kinase/Akt signaling pathway.
    Wang C; Liu X; Ke Z; Tang Y; Li CC; Li CM; Ye Z; Zhang J; Lou T
    Cell Physiol Biochem; 2012; 29(5-6):743-52. PubMed ID: 22613975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parathyroid hormone-related protein induces hypertrophy in podocytes via TGF-beta(1) and p27(Kip1): implications for diabetic nephropathy.
    Romero M; Ortega A; Izquierdo A; López-Luna P; Bosch RJ
    Nephrol Dial Transplant; 2010 Aug; 25(8):2447-57. PubMed ID: 20200004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.